Arcturus Therapeutics Holdings (ARCT) Free Cash Flow: 2018-2025
Historic Free Cash Flow for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to -$17.3 million.
- Arcturus Therapeutics Holdings' Free Cash Flow rose 27.31% to -$17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.6 million, marking a year-over-year increase of 4.82%. This contributed to the annual value of -$60.4 million for FY2024, which is 187.60% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Free Cash Flow stood at -$17.3 million for Q3 2025, which was down 201.16% from -$5.8 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Free Cash Flow ranged from a high of $156.5 million in Q4 2022 and a low of -$51.1 million during Q1 2022.
- Over the past 3 years, Arcturus Therapeutics Holdings' median Free Cash Flow value was -$17.3 million (recorded in 2025), while the average stood at -$12.7 million.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Free Cash Flow spiked by 458.71% in 2022 and then slumped by 508.50% in 2025.
- Over the past 5 years, Arcturus Therapeutics Holdings' Free Cash Flow (Quarterly) stood at -$43.6 million in 2021, then surged by 458.71% to $156.5 million in 2022, then tumbled by 100.96% to -$1.5 million in 2023, then surged by 81.12% to -$284,000 in 2024, then rose by 27.31% to -$17.3 million in 2025.
- Its last three reported values are -$17.3 million in Q3 2025, -$5.8 million for Q2 2025, and -$35.3 million during Q1 2025.